Category
Drug Product CDMOs
Compare drug product CDMOs for formulation development, solid oral dosage, sterile injectables, and specialty dosage forms. Filter by dosage type, scale, and certifications.
1365 companies listed
About Drug Product Manufacturing
Drug product manufacturing transforms active pharmaceutical ingredients into the finished dosage forms patients use. This includes solid oral dosage (tablets, capsules), sterile injectables (vials, pre-filled syringes), semi-solids (creams, gels), and specialty forms (transdermal patches, inhalers, implants).
Formulation development is where science meets engineering. A CDMO's formulation team determines bioavailability, stability, and manufacturability. For poorly soluble compounds, techniques like spray drying, hot melt extrusion, and nano-milling can be the difference between a viable product and a failed program. Ask for specific experience with your compound class.
What scale do you need? Clinical-phase drug product often runs in batches of 5,000-50,000 units. Commercial scale might mean millions of units per month. Few CDMOs cover the full range efficiently. Match your current and projected volumes to a CDMO with the right equipment and batch size flexibility.
Companies (1365)
Senn Chemicals AG
Switzerland
Senn Chemicals AG is a Swiss CDMO specializing in peptide APIs, peptide fragments, amino acid derivatives, and small molecules. Founded in 1963 in Dielsdorf near Zurich, the company provides cGMP custom manufacturing services from early research to commercial phase. Senn Chemicals has been inspected multiple times by the US FDA and was acquired by Granules India in 2025 to expand peptide therapeutics and CDMO capabilities.
Small Molecule APIFormulation DevelopmentAnalytical Services
Serán BioScience
United States
Seran BioScience is a US-based CDMO headquartered in Bend, Oregon, recognized as a world leader in drug delivery and formulation development. The company provides comprehensive drug development and clinical/commercial manufacturing services, specializing in spray drying and particle engineering, preformulation, dosage form development, and cGMP manufacturing. Seran recently secured $200M+ from Bain Capital to build a new 100,000 sqft commercial manufacturing facility for non-sterile oral solid dose pharmaceuticals.
Frequently Asked Questions
What is drug product manufacturing?+
Drug product manufacturing converts APIs into final dosage forms for patients. The process includes formulation development (choosing excipients, optimizing bioavailability), process development (granulation, compression, coating, filling), analytical method development, stability testing, and scale-up to commercial volumes. It also covers packaging and labeling.
What dosage forms can drug product CDMOs produce?+
Common dosage forms include tablets (immediate-release, modified-release, orally disintegrating), capsules (hard gelatin, HPMC, softgel), sterile injectables (lyophilized, liquid), semi-solids (creams, ointments, gels), liquids (solutions, suspensions, syrups), and specialty forms (transdermal patches, inhalers, suppositories, implants). Most CDMOs specialize in 2-3 dosage forms rather than offering all.
Need help finding the right CDMO?
Our AI Matchmaker analyzes your project requirements and matches you with qualified manufacturing partners. Free for buyers.
